Skip to main content

Table 1 Correlation between coNLR-PDW and clinicopathological features or hematological parameters

From: Prognostic value of inflammation-based indices in patients with resected hepatocellular carcinoma

Variables Number of patients co NLR-PDW 0 co NLR-PDW 1 co NLR-PDW 2 P-value
Age, < 60/≥60 years 194/56 31/11 108/35 55/10 0.281
Gender, male/female 225/25 36/6 129/14 60/5 0.536
HBsAg, negative/positive 29/221 5/37 17/126 7/58 0.971
Cirrhosis, no/yes 79/171 21/21 42/99 16/44 0.004
Tumor size, ≤5/> 5 cm 137/113 31/11 69/74 37/28 0.013
Tumor number, single/multiple 179/71 32/10 99/44 48/17 0.609
AFP, < 400/≥400 ng/ml 170/80 26/16 98/45 46/19 0.617
Vascular invasion, no/yes 146/104 28/14 77/66 41/24 0.225
Child-Pugh grade, A/B 235/15 41/1 137/6 57/8 0.041
BCLC, 0-A/ B-C 19/79/48/104 23/19 50/93 25/40 0.069
Differentiation, well moderate/poor 41/189/20 40/2 130/13 60/5 0.658
PT (s) 13.6 (12.9–14.2) 13.4 (12.7–14.1) 13.6 (13.0–14.4) 13.5 (13.1–14.2) 0.143
ALT (U/L) 38.0 (26.0–52.3) 35.0 (22.5–46.5) 40.0 (27.8–57.5) 39.0 (26.0–50.0) 0.093
TB (umol/L) 14.7 (10.7–18.3) 13.9 (9.8–16.0) 14.3 (10.8–18.2) 15.8 (12.4–20.5) 0.032
GGT (U/L) 60.5 (37.0–117.5) 49.0 (26.0–98.0) 64.5 (38.0–119.5) 70.0 (43.0–135.0) 0.055
ALB (g/L) 40.0 ± 4.2 40.3 ± 3.7 39.5 ± 4.1 41.0 ± 4.6 0.053
MPV (Fl) 10.6 (9.9–11.2) 9.8 (9.4–10.2) 10.6 (10.0–11.2) 11.2 (10.8–11.6) < 0.001
  1. Notes: AFP alpha fetoprotein, BCLC Barcelona Clinic Liver Cancer, PT prothrombin time, ALT Alanine transaminase, TB total bilirubin, GGT gamma-glutamyl transpeptidase, ALB albumin, MPV mean platelet volume, coNLR-PDW combination of NLR and PDW